Literature DB >> 10092780

IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control.

S Herblot1, P Chastagner, L Samady, J L Moreau, C Demaison, P Froussard, X Liu, J Bonnet, J Thèze.   

Abstract

IL-2 induces growth, differentiation, and/or apoptosis of lymphoid cells. To study further the molecular basis of IL-2 function, we used a cDNA subtraction approach involving a cell line grown in IL-2 or IL-4. From the corresponding library, 66 nonredundant sequences were characterized; 16 of them encode identified proteins. The kinetics of in vitro expression of 8 selected sequences, the functions of which could be associated with IL-2-induced T cell activation/differentiation, was investigated using an IL-2-dependent T cell line. IL-2 increased the expression of cytoskeleton proteins (alpha-tubulin), oncogene-regulating proteins (CCCTC-binding factor, Jun inhibitor factor-1), and transcription factors (E2F-4, cyclic AMP-responsive element-binding protein, zhx-1). IL-2 also regulated the expression of genes coding for multifunctional proteins, e.g., beta-catenin and nucleolin. These results were verified using Con A-induced T cell blasts stimulated or not by IL-2. The in vivo expression of four of these genes was also analyzed in spleen and lymph node cells of IL-2-deficient and MRL/lpr mice, which both have high numbers of activated cells, but the latter have intact IL-2 expression. The expression of beta-catenin, CCCTC-binding factor, Jun inhibitor factor-1, and nucleolin was significantly higher in MRL/lpr animals. A similar analysis of thymocytes from IL-2-/- and IL-2+/- mice demonstrated the same expression patterns of the 4 sequences in these strains. The expression of the IL-2-induced genes described herein is similar to the regulatory pattern of IL-2R alpha. Taken together, our data provide additional evidence for the pleiotropic action of IL-2 in the periphery and IL-2 independence of molecular processes involved in thymocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor.

Authors:  Hiroko Kawata; Kazuya Yamada; Zhangfei Shou; Tetsuya Mizutani; Takashi Yazawa; Miki Yoshino; Toshio Sekiguchi; Takashi Kajitani; Kaoru Miyamoto
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

2.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis.

Authors:  P J Greasley; C Bonnard; B Amati
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

3.  Thrombopoietin upregulates nucleolin mRNA and protein in thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

Authors:  Takatoshi Ito; Mitsuhiro Fujihara; Atsushi Oda; Shinobu Wakamoto; Miki Yamaguchi; Norio Komatsu; Hiroshi Miyazaki; Hiroshi Azuma; Hisami Ikeda; Kenji Ikebuchi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

4.  miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation.

Authors:  Samir Kelada; Praveen Sethupathy; Isobel S Okoye; Eleni Kistasis; Stephanie Czieso; Sandra D White; David Chou; Craig Martens; Stacy M Ricklefs; Kimmo Virtaneva; Dan E Sturdevant; Stephen F Porcella; Yasmine Belkaid; Thomas A Wynn; Mark S Wilson
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

5.  Medical immunology: a new journal for a new subspecialty.

Authors:  Kendall A Smith
Journal:  Med Immunol       Date:  2002-09-30

6.  DNA array analysis of interleukin-2-regulated immediate/early genes.

Authors:  Carol Beadling; Kendall A Smith
Journal:  Med Immunol       Date:  2002-11-18

7.  Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.

Authors:  Edgar Grinstein; Peter Wernet; Peter J F Snijders; Frank Rösl; Inge Weinert; Wentao Jia; Regine Kraft; Christiane Schewe; Michael Schwabe; Steffen Hauptmann; Manfred Dietel; Chris J L M Meijer; Hans-Dieter Royer
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.